This was not associated with the age, initial stage, tumor grade, ER/PR or HER2 expression level, Ki67 status, presence of visceral or brain metastases, type of previously received treatment, or number of treatment lines (all p > 0.05; see Supplementary Materials Tables S1–S20). This evidence concerns the gene ESR1 and neoplasm.